pharvaris.com (PHVS) Company Sales Volume

Corporate emblem and logo of pharvaris.com (PHVS)

Pharvaris N.V. is pursuing super-profitability by transitioning from injections to accessible tablets. The company's sales trend confirms revenue dynamics, where the value 0.00 indicates the current magnitude. Profitability will increase driven by NAO therapy and insurance payouts. Organic pipeline growth makes the business an attractive acquisition target for corporate behemoths.

PHVS Pharvaris NV: Company Revenue in the range 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for Pharvaris NV (PHVS)

- price and consensus price forecast:
Comprehensive company analysis:Pharvaris - PHVS
Flagship merchandise of Pharvaris

The current sales performance of Pharvaris N.V. (PHVS) characterizes the market status of this biotech issuer. This metric aggregates actual drug sales volumes, filtering out market volatility and emotional trader reactions. This price action reflects real business expansion, where steady growth signals the capture of market share. For Pharvaris N.V. (PHVS), this volume depends directly on the effectiveness of ESG standard implementation and the modernization of research centers. A stable trend confirms the commercial viability of rare drug developments.

Competing companies

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|AbCellera Biologics Inc. - Company Revenue|Tourmaline Bio Inc - Revenue and Sales Volume|Company Total Sales Volume Intrexon (PGEN)|Pharming Group (PHAR) - Company Revenue|Nektar Therapeutics Inc. - Company Sales Revenue|Company Sales UPB|Zenas Bio (ZBIO) - Company Gross Revenue|Company Sales IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Company Sales Revenue|Company Revenue KalVista Pharmaceuticals Inc KALV|Company Gross Revenue septerna.com (SEPN)|PVLA - Company Revenue|Company Gross Revenue Savara Inc SVRA|RIGL: Revenue and Sales Volume|ANAB - Company Gross Revenue|Company Revenue Astria Pharma|Company Sales Volume ENGN (enGene Holdings Inc.)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Revenue and Sales Volume Aerovate Therapeutics, Inc. (JBIO)|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume